Variant report

Variant	nsv885813
Chromosome Location	chr6:36702843-36713720
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

TF binding
region (count:192)
CpG islands
(count:122)
Chromatin interactive
region (count:33)
LncRNA
region (count:0)
Mature miRNA
region (count: 0)
miRNA target
sites (count:0)

(count:192 , 50 per page) page: 1 2 3 4

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	BHLHE40	chr6:36708312-36708547	GM12878	blood:	n/a	n/a
2	BHLHE40	chr6:36708380-36708460	K562	blood:	n/a	n/a
3	BHLHE40	chr6:36710914-36711102	HepG2	liver:	n/a	n/a
4	BHLHE40	chr6:36708418-36708433	HepG2	liver:	n/a	n/a
5	CEBPB	chr6:36702907-36703264	IMR90	lung:	n/a	n/a
6	CREB1	chr6:36713614-36713996	K562	blood:	n/a	chr6:36713808-36713821
7	CTCF	chr6:36702900-36703050	GM12866	blood:	n/a	n/a
8	CTCF	chr6:36702940-36703090	HPAF	blood vessel:	n/a	n/a
9	CTCF	chr6:36702840-36702990	HBMEC	blood vessel:	n/a	n/a
10	CTCF	chr6:36702880-36703030	HMF	breast:	n/a	n/a
11	CTCF	chr6:36703660-36703810	HCPEpiC	choroid plexus:	n/a	n/a
12	CTCF	chr6:36703660-36703810	HCM	heart:	n/a	n/a
13	CTCF	chr6:36702880-36703030	HL-60	blood:	n/a	n/a
14	CTCF	chr6:36702904-36703009	GM12878	blood:	n/a	n/a
15	CTCF	chr6:36702900-36703050	AG09319	gingival:	n/a	n/a
16	CTCF	chr6:36702900-36703050	HPF	lung:	n/a	n/a
17	CTCF	chr6:36703540-36703690	HUVEC	blood vessel:	n/a	n/a
18	CTCF	chr6:36703140-36703290	WERI-Rb-1	eye:	n/a	n/a
19	CTCF	chr6:36702820-36702970	HAc	cerebellar:	n/a	n/a
20	CTCF	chr6:36702904-36703044	K562	blood:	n/a	n/a
21	CTCF	chr6:36703580-36703730	BJ	skin:	n/a	n/a
22	CTCF	chr6:36702900-36703050	GM12878	blood:	n/a	n/a
23	CTCF	chr6:36702893-36703008	Fibrobl	skin:	n/a	n/a
24	CTCF	chr6:36702960-36703110	GM12872	blood:	n/a	n/a
25	CTCF	chr6:36702880-36703030	GM12874	blood:	n/a	n/a
26	CTCF	chr6:36702910-36703022	GM13977	blood:	n/a	n/a
27	CTCF	chr6:36703800-36703950	AoAF	blood vessel:	n/a	n/a
28	CTCF	chr6:36702840-36702990	GM12875	blood:	n/a	n/a
29	CTCF	chr6:36702887-36702888	Fibrobl	skin:	n/a	n/a
30	CTCF	chr6:36702920-36702984	GM13976	blood:	n/a	n/a
31	CTCF	chr6:36702920-36703070	AG09309	skin:	n/a	n/a
32	CTCF	chr6:36702859-36703060	GM19238	blood:	n/a	n/a
33	CTCF	chr6:36702880-36703030	GM12864	blood:	n/a	n/a
34	CTCF	chr6:36702800-36702950	HCM	heart:	n/a	n/a
35	CTCF	chr6:36702880-36703030	GM12868	blood:	n/a	n/a
36	CTCF	chr6:36702900-36703050	HMEC	breast:	n/a	n/a
37	CTCF	chr6:36703795-36703886	Lung_OC	lung:	n/a	n/a
38	CTCF	chr6:36702860-36703010	BJ	skin:	n/a	n/a
39	CTCF	chr6:36702951-36703023	Gliobla	brain:	n/a	n/a
40	CTCF	chr6:36702900-36703050	AG04449	skin:	n/a	n/a
41	CTCF	chr6:36703640-36703790	AoAF	blood vessel:	n/a	n/a
42	CTCF	chr6:36702860-36703010	WI-38	lung:	n/a	n/a
43	CTCF	chr6:36702840-36702990	GM12873	blood:	n/a	n/a
44	CTCF	chr6:36702940-36703090	HEEpiC	esophagus:	n/a	n/a
45	CTCF	chr6:36702871-36703064	Spleen_OC	spleen:	n/a	n/a
46	CTCF	chr6:36702940-36703090	NHLF	lung:	n/a	n/a
47	CTCF	chr6:36702860-36703010	HCM	heart:	n/a	n/a
48	CTCF	chr6:36703660-36703810	AG04450	lung:	n/a	n/a
49	CTCF	chr6:36702920-36703070	AoAF	blood vessel:	n/a	n/a
50	CTCF	chr6:36702880-36703030	GM12870	blood:	n/a	n/a

(count:122 , 50 per page) page: 1 2 3

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr6:36703127-36703177	HEK293	kidney:	embryo
2	chr6:36709214-36709264	CMK	blood:	n/a
3	chr6:36703127-36703177	AoSMC	blood vessel:	n/a
4	chr6:36703127-36703177	PFSK-1	brain:	n/a
5	chr6:36709214-36709264	NT2-D1	testis:	n/a
6	chr6:36703127-36703177	Caco-2	colon:	n/a
7	chr6:36709214-36709264	SK-N-SH_RA	brain:	n/a
8	chr6:36703127-36703177	SK-N-SH	brain:	n/a
9	chr6:36703127-36703177	CMK	blood:	n/a
10	chr6:36703127-36703177	HRE	kidney:	n/a
11	chr6:36703127-36703177	RPTEC	kidney:	n/a
12	chr6:36709214-36709264	HEEpiC	esophagus:	n/a
13	chr6:36709214-36709264	HL-60	blood:	n/a
14	chr6:36703127-36703177	AG04449	skin:	fetal
15	chr6:36709214-36709264	AG09319	gingival:	n/a
16	chr6:36709214-36709264	HMEC	breast:	n/a
17	chr6:36709214-36709264	NH-A	brain:	n/a
18	chr6:36709214-36709264	AG04450	lung:	fetal
19	chr6:36703127-36703177	Hela-S3	cervix:	n/a
20	chr6:36703127-36703177	Jurkat	blood:	n/a
21	chr6:36703127-36703177	AG09319	gingival:	n/a
22	chr6:36709214-36709264	HUVEC	blood vessel:	n/a
23	chr6:36709214-36709264	GM19239	blood:	n/a
24	chr6:36709214-36709264	GM06990	blood:	n/a
25	chr6:36703127-36703177	GM19239	blood:	n/a
26	chr6:36703127-36703177	NH-A	brain:	n/a
27	chr6:36703127-36703177	HIPEpiC	eye:	n/a
28	chr6:36709214-36709264	SK-N-SH	brain:	n/a
29	chr6:36703127-36703177	SK-N-SH_RA	brain:	n/a
30	chr6:36709214-36709264	A549	lung:	n/a
31	chr6:36703127-36703177	HCM	heart:	n/a
32	chr6:36703127-36703177	NHBE	bronchial:	n/a
33	chr6:36709214-36709264	SKMC	muscle:	n/a
34	chr6:36703127-36703177	T-47D	breast:	n/a
35	chr6:36709214-36709264	HRE	kidney:	n/a
36	chr6:36709214-36709264	HAEpiC	amniotic membrane:	n/a
37	chr6:36709214-36709264	PFSK-1	brain:	n/a
38	chr6:36709214-36709264	Caco-2	colon:	n/a
39	chr6:36703127-36703177	PANC-1	pancreas:	n/a
40	chr6:36703127-36703177	MCF10A-Er-Src	breast:	n/a
41	chr6:36703127-36703177	H1-hESC	embryonic stem cell:	embryo
42	chr6:36709214-36709264	IMR90	lung:	fetal
43	chr6:36703127-36703177	HAEpiC	amniotic membrane:	n/a
44	chr6:36709214-36709264	HRCEpiC	kidney:	n/a
45	chr6:36703127-36703177	HL-60	blood:	n/a
46	chr6:36709214-36709264	PrEC	prostate:	n/a
47	chr6:36703127-36703177	SKMC	muscle:	n/a
48	chr6:36709214-36709264	AG04449	skin:	fetal
49	chr6:36703127-36703177	SK-N-MC	brain:	n/a
50	chr6:36703127-36703177	GM06990	blood:	n/a

(count:33 , 50 per page) page: 1

No.	Distal block	Cell Line	Cell type
1	chr6:36706267..36708533-chr6:36712946..36714916,2	K562	blood:
2	chr6:36706791..36710785-chr6:36712838..36716064,4	MCF-7	breast:
3	chr6:36706145..36708888-chr6:36709331..36711123,2	MCF-7	breast:
4	chr6:36563235..36565666-chr6:36712198..36714107,2	K562	blood:
5	chr6:36706145..36708888-chr6:36709331..36711123,2	MCF-7	breast:
6	chr6:36658059..36660618-chr6:36709664..36711830,2	MCF-7	breast:
7	chr6:36711266..36713245-chr6:36715954..36717794,2	MCF-7	breast:
8	chr6:36681851..36683948-chr6:36705203..36707828,2	K562	blood:
9	chr6:36708918..36710565-chr6:36712727..36715586,2	K562	blood:
10	chr6:36575316..36577688-chr6:36710838..36712742,2	K562	blood:
11	chr6:36671517..36673727-chr6:36709746..36712131,2	K562	blood:
12	chr6:36710180..36712510-chr6:36716987..36718768,2	K562	blood:
13	chr6:36704975..36706910-chr6:36710272..36712382,2	MCF-7	breast:
14	chr6:36710588..36713306-chr6:36722738..36724865,2	MCF-7	breast:
15	chr6:36635018..36637044-chr6:36710933..36713268,2	K562	blood:
16	chr6:36705103..36707775-chr6:36711430..36713266,2	MCF-7	breast:
17	chr6:36646178..36648267-chr6:36708912..36712169,4	MCF-7	breast:
18	chr6:36705988..36708979-chr6:36709402..36712073,2	K562	blood:
19	chr6:36561849..36563615-chr6:36700031..36702846,2	K562	blood:
20	chr6:36706267..36708533-chr6:36712946..36714916,2	K562	blood:
21	chr6:36705988..36708979-chr6:36709402..36712073,2	K562	blood:
22	chr6:36705103..36707775-chr6:36711430..36713266,2	MCF-7	breast:
23	chr6:36708140..36710606-chr6:36718569..36720077,2	MCF-7	breast:
24	chr6:36708174..36711394-chr6:36720287..36721932,3	MCF-7	breast:
25	chr6:36646077..36648615-chr6:36711852..36713395,2	K562	blood:
26	chr6:36645227..36647717-chr6:36711034..36713028,2	K562	blood:
27	chr6:36708918..36710565-chr6:36712727..36715586,2	K562	blood:
28	chr6:36682976..36685028-chr6:36712488..36714251,2	MCF-7	breast:
29	chr6:36704975..36706910-chr6:36710272..36712382,2	MCF-7	breast:
30	chr6:36692869..36694899-chr6:36700775..36703080,2	MCF-7	breast:
31	chr6:36583432..36585248-chr6:36700120..36704013,3	MCF-7	breast:
32	chr6:36588827..36591407-chr6:36708568..36710825,2	MCF-7	breast:
33	chr6:36706791..36710785-chr6:36712838..36716064,4	MCF-7	breast:

No data

Variant related genes	Relation type
ENSG00000220349	TF binding region
ENSG00000220349	CpG island
ENSG00000255587	chromatin interactions
ENSG00000124762	chromatin interactions
ENSG00000112081	chromatin interactions
ENSG00000263894	chromatin interactions

Extended variants
information (count: 496 )
Associated
traits (count: 87 )

Variant overlapped rSNPs/rCNVs (count:496 , 50 per page) page: 1 2 3 4 5 6 7 ... 10

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs236449	chr6:36702843-36702844	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region Chromatin interactive region	2 gene(s)	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs545391929	chr6:36702849-36702850	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
3	rs530054759	chr6:36702862-36702863	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
4	rs143894399	chr6:36702867-36702868	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
5	rs569579863	chr6:36702877-36702878	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
6	rs536866415	chr6:36702898-36702899	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
7	rs113707476	chr6:36702907-36702908	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
8	rs570294978	chr6:36702921-36702922	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
9	rs534458314	chr6:36702943-36702944	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
10	rs553032543	chr6:36702954-36702955	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
11	rs574355066	chr6:36702960-36702961	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
12	rs535391103	chr6:36702966-36702967	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
13	rs74796013	chr6:36702976-36702977	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Flanking Bivalent TSS/Enh Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
14	rs191850860	chr6:36703017-36703018	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
15	rs184035137	chr6:36703064-36703065	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
16	rs115486000	chr6:36703065-36703066	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
17	rs187629205	chr6:36703079-36703080	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
18	rs41439445	chr6:36703095-36703096	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
19	rs200467192	chr6:36703119-36703120	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
20	rs559756868	chr6:36703128-36703129	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
21	rs530055775	chr6:36703158-36703159	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
22	rs548150529	chr6:36703159-36703160	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
23	rs192076458	chr6:36703161-36703162	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
24	rs542271330	chr6:36703175-36703176	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region CpG island	1 gene(s)	Overlapped CNVs	n/a
25	rs530745439	chr6:36703233-36703234	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
26	rs557159152	chr6:36703277-36703278	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
27	rs80296862	chr6:36703295-36703296	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
28	rs370336762	chr6:36703305-36703306	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
29	rs546389359	chr6:36703342-36703343	Flanking Bivalent TSS/Enh Enhancers Bivalent Enhancer Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
30	rs150027583	chr6:36703404-36703405	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
31	rs375194892	chr6:36703487-36703488	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
32	rs185747002	chr6:36703513-36703514	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
33	rs557024368	chr6:36703526-36703527	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
34	rs7759362	chr6:36703530-36703531	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
35	rs373033194	chr6:36703531-36703532	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
36	rs141209189	chr6:36703532-36703533	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
37	rs190605962	chr6:36703538-36703539	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
38	rs76524577	chr6:36703546-36703547	Bivalent/Poised TSS Enhancers Bivalent Enhancer Flanking Active TSS Weak transcription Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
39	rs573917559	chr6:36703603-36703604	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
40	rs559613446	chr6:36703610-36703611	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
41	rs553994029	chr6:36703611-36703612	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
42	rs145065395	chr6:36703620-36703621	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
43	rs531201574	chr6:36703636-36703637	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
44	rs78221659	chr6:36703659-36703660	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
45	rs563381446	chr6:36703676-36703677	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
46	rs147560217	chr6:36703690-36703691	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
47	rs142314328	chr6:36703701-36703702	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
48	rs370812248	chr6:36703714-36703715	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
49	rs564367369	chr6:36703749-36703750	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a
50	rs528293181	chr6:36703776-36703777	Bivalent Enhancer Enhancers Weak transcription Flanking Active TSS Active TSS	TF binding region	1 gene(s)	Overlapped CNVs	n/a

Variant related diseases (count:87)

Disease	PMID	Source
Follicular lymphoma	20505157	CNVD
Glioblastoma multiforme	21080181	CNVD
Ewing''s sarcoma	21437220	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Leukemia	21518781	CNVD
Cancer	21637783	CNVD
Facial dysmorphism	22105932	CNVD
Medulloblastoma	21979893	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Diffuse large b-cell lymphoma	18287131	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Glioblastoma multiforme	19960244	CNVD
Hepatocellular carcinoma	22174799	CNVD
Endometrial cancer	22040021	CNVD
Acute myeloid leukemia	16864856	CNVD
Breast cancer	21264507	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Cancer	16751803	CNVD
Bladder cancer	19088036	CNVD
Wilms tumour	21544195	CNVD
Uveal melanoma	21693616	CNVD
Biliary cancer	19435499	CNVD
Malaria	21533027	CNVD
Retinoblastoma	19183342	CNVD
Acute myeloid leukemia	20729466	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Acute lymphoblastic leukemia	20435627	CNVD
Prostate cancer	18632612	CNVD
Breast cancer	21858162	CNVD
Ewing''s sarcoma	17952124	CNVD
Autism	21448237	CNVD
Melanoma	18172304	CNVD
Breast cancer	20668451	CNVD
Cancer	20668451	CNVD
Lung cancer	20668451	CNVD
Ovarian cancer	20668451	CNVD
Pancreas cancer	20668451	CNVD
Prostate cancer	20668451	CNVD
Chronic lymphocytic leukemia	21546498	CNVD
Hepatocellular carcinoma	16750200	CNVD
Autism	22495311	CNVD
Cancer	16790693	CNVD
Cervical cancer	21062161	CNVD
Systemic lupus erythematosus	17503323	CNVD
Endometrioid adenocarcinoma	16974079	CNVD
Urothelial carcinoma	18382360	CNVD
Cancer	21183584	CNVD
Hodgkin''s lymphoma	17606441	CNVD
small cell lung cancer	20016488	CNVD
Oral squamous cell carcinoma	17134496	CNVD
Gastric cancer	17908304	CNVD
Metanephric adenoma	20802469	CNVD
Splenic marginal zone lymphoma	21957467	CNVD
Malignant peripheral nerve sheath tumor	18522746	CNVD
Neuroblastoma	16790693	CNVD
T-cell prolymphocytic leukemia	17713554	CNVD
Breast cancer	16397240	CNVD
Retinoblastoma	22278416	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Systemic lupus erythematosus	20877625	CNVD
Cleidocranial dysplasia	18696259	CNVD
Holoprosencephaly	21359414	CNVD
Liposarcoma	21253554	CNVD
Uveal melanoma	20484589	CNVD
Fibroblasts	20926602	CNVD
Osteosarcoma	16790693	CNVD
Biliary cancer	20360734	CNVD
Breast cancer	20360734	CNVD
Coronary artery disease	20360734	CNVD
Crohn''s disease	20360734	CNVD
Hypertension	20360734	CNVD
Rheumatoid arthritis	20360734	CNVD
Type 1 diabetes	20360734	CNVD
Type 2 diabetes	20360734	CNVD
Cancer	22183965	CNVD
Melanoma	22183965	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Lung cancer	18438408	CNVD
Glioblastoma multiforme	21138945	CNVD
Breast cancer	21364760	CNVD
Myelofibrosis	22110671	CNVD
Liver carcinoma	19366792	CNVD
Chronic lymphocytic leukemia	22228453	CNVD
Lung cancer	19153074	CNVD
Ovarian cancer	21720365	CNVD
early-passage human iPS cells	21368824	CNVD

Chromatin state (count:380 , 50 per page) page: 1 2 3 4 5 6 7 8

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr6:36694000-36703000	Weak transcription	Ganglion Eminence derived primary cultured neurospheres	brain
2	chr6:36699200-36703200	Weak transcription	HUES64 Cell Line	embryonic stem cell
3	chr6:36699200-36703400	Weak transcription	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
4	chr6:36702000-36704000	Enhancers	Primary monocytes fromperipheralblood	blood
5	chr6:36702200-36703800	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
6	chr6:36702200-36703800	Enhancers	Primary Natural Killer cells fromperipheralblood	blood
7	chr6:36702200-36703800	Enhancers	Spleen	Spleen
8	chr6:36702200-36704000	Enhancers	Esophagus	oesophagus
9	chr6:36702200-36704000	Enhancers	Sigmoid Colon	Sigmoid Colon
10	chr6:36702200-36704200	Enhancers	Stomach Mucosa	stomach
11	chr6:36702200-36704800	Enhancers	Lung	lung
12	chr6:36702400-36703000	Bivalent Enhancer	H1 Derived Mesenchymal Stem Cells	ES cell derived
13	chr6:36702400-36703000	Enhancers	Fetal Brain Male	brain
14	chr6:36702400-36703000	Enhancers	Left Ventricle	heart
15	chr6:36702400-36703000	Enhancers	Ovary	ovary
16	chr6:36702400-36703400	Flanking Active TSS	Primary neutrophils fromperipheralblood	blood
17	chr6:36702400-36703400	Bivalent Enhancer	Primary hematopoietic stem cells short term culture	blood
18	chr6:36702400-36703400	Bivalent Enhancer	Placenta	Placenta
19	chr6:36702400-36703400	Enhancers	Fetal Thymus	thymus
20	chr6:36702400-36703400	Enhancers	GM12878-XiMat	blood
21	chr6:36702400-36703600	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
22	chr6:36702400-36703600	Flanking Active TSS	Adipose Derived Mesenchymal Stem Cell Cultured Cells	ES cell derived
23	chr6:36702400-36703600	Enhancers	Primary T helper 17 cells PMA-I stimulated	--
24	chr6:36702400-36703600	Enhancers	Primary T killer naive cells fromperipheralblood	blood
25	chr6:36702400-36703600	Flanking Active TSS	Adipose Nuclei	Adipose
26	chr6:36702400-36703600	Flanking Active TSS	Monocytes-CD14+_RO01746	blood
27	chr6:36702400-36703800	Enhancers	Placenta Amnion	Placenta Amnion
28	chr6:36702400-36704000	Enhancers	Psoas Muscle	Psoas
29	chr6:36702400-36704000	Enhancers	Right Atrium	heart
30	chr6:36702400-36704000	Enhancers	Right Ventricle	heart
31	chr6:36702400-36704200	Enhancers	Small Intestine	intestine
32	chr6:36702600-36703000	Bivalent Enhancer	ES-I3 Cell Line	embryonic stem cell
33	chr6:36702600-36703000	Flanking Active TSS	Breast Myoepithelial Primary Cells	Breast
34	chr6:36702600-36703000	Enhancers	Primary T cells fromperipheralblood	blood
35	chr6:36702600-36703000	Flanking Bivalent TSS/Enh	Foreskin Fibroblast Primary Cells skin01	Skin
36	chr6:36702600-36703000	Flanking Active TSS	Rectal Smooth Muscle	rectum
37	chr6:36702600-36703200	Enhancers	Primary T helper naive cells from peripheral blood	blood
38	chr6:36702600-36703200	Enhancers	Primary T helper naive cells fromperipheralblood	blood
39	chr6:36702600-36703200	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Female	--
40	chr6:36702600-36703200	Bivalent Enhancer	Fetal Intestine Small	intestine
41	chr6:36702600-36703400	Enhancers	Primary hematopoietic stem cells	blood
42	chr6:36702600-36703400	Enhancers	Primary T helper memory cells from peripheral blood 2	blood
43	chr6:36702600-36703400	Enhancers	Primary T helper cells fromperipheralblood	blood
44	chr6:36702600-36703400	Flanking Active TSS	Primary hematopoietic stem cells G-CSF-mobilized Male	--
45	chr6:36702600-36703400	Flanking Active TSS	Foreskin Keratinocyte Primary Cells skin02	Skin
46	chr6:36702600-36703400	Enhancers	Primary mononuclear cells fromperipheralblood	Blood
47	chr6:36702600-36703400	Flanking Active TSS	Colonic Mucosa	Colon
48	chr6:36702600-36703400	Enhancers	HMEC	breast
49	chr6:36702600-36703400	Flanking Active TSS	NHEK	skin
50	chr6:36702600-36703400	Flanking Active TSS	NHLF	lung

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links